These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 18346169)

  • 1. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
    Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
    Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
    J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
    McCallum RW; Cynshi O;
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.
    Ozaki K; Yogo K; Sudo H; Onoma M; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Pharmacology; 2007; 79(4):223-35. PubMed ID: 17426410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs.
    Ozaki K; Sudo H; Muramatsu H; Yogo K; Kamei K; Koga H; Itoh Z; Omura S; Takanashi H
    Inflammopharmacology; 2007 Feb; 15(1):36-42. PubMed ID: 17323194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis.
    Takanashi H; Cynshi O
    Regul Pept; 2009 Jun; 155(1-3):18-23. PubMed ID: 19345243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
    Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
    Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
    Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: a pilot study.
    Nakamura T; Ishii M; Arai Y; Tandoh Y; Terada A; Takebe K
    Clin Ther; 1994; 16(6):989-99. PubMed ID: 7697695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
    Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
    Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys.
    Yogo K; Onoma M; Ozaki K; Koto M; Itoh Z; Omura S; Takanashi H
    Dig Dis Sci; 2008 Apr; 53(4):912-8. PubMed ID: 17934842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
    Richards RD; Davenport K; McCallum RW
    Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
    Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
    Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy.
    Kawagishi T; Nishizawa Y; Okuno Y; Sekiya K; Morii H
    Am J Gastroenterol; 1993 Jun; 88(6):933-8. PubMed ID: 8503391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
    Dutta U; Padhy AK; Ahuja V; Sharma MP
    Trop Gastroenterol; 1999; 20(3):116-9. PubMed ID: 10695417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorating effects and mechanisms of electroacupuncture on gastric dysrhythmia, delayed emptying, and impaired accommodation in diabetic rats.
    Yin J; Chen J; Chen JD
    Am J Physiol Gastrointest Liver Physiol; 2010 Apr; 298(4):G563-70. PubMed ID: 20093561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclooxygenase-2 inhibitor on glucagon-induced delayed gastric emptying and gastric dysrhythmia in dogs.
    Xu J; Chen JD
    Neurogastroenterol Motil; 2007 Feb; 19(2):144-51. PubMed ID: 17244169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.
    Janssens J; Peeters TL; Vantrappen G; Tack J; Urbain JL; De Roo M; Muls E; Bouillon R
    N Engl J Med; 1990 Apr; 322(15):1028-31. PubMed ID: 2320062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.